Amedisys Inc (AMED) Financial Statements (2026 and earlier)

Company Profile

Business Address 3854 AMERICAN WAY
BATON ROUGE, LA 70816
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 8082 - Home Health Care Services (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments284,881303,242245,450149,883108,234126,450
Cash and cash equivalent284,881303,242245,450149,883108,234126,450
Receivables319,639296,075301,050356,909359,359313,373
Prepaid expense17,41013,07220,48515,51020,33214,639
Other current assets12,03419,69412,96226,12526,05330,060
Other undisclosed current assets    7,47512,47012,413
Total current assets:633,964632,083579,947555,902526,448496,935
Noncurrent Assets
Operating lease, right-of-use asset80,90581,50085,11084,69288,42588,939
Property, plant and equipment40,18642,10842,00044,65442,68441,845
Intangible assets, net (including goodwill)1,294,0871,295,0431,344,3771,345,5111,346,4571,347,354
Goodwill1,213,8881,213,8881,244,6791,244,6791,244,6791,244,679
Intangible assets, net (excluding goodwill)80,19981,15599,698100,832101,778102,675
Other noncurrent assets135,43287,98087,68086,60985,85785,097
Total noncurrent assets:1,550,6101,506,6311,559,1671,561,4661,563,4231,563,235
TOTAL ASSETS:2,184,5742,138,7142,139,1142,117,3682,089,8712,060,170
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities190,885192,520177,728173,664183,713168,286
Accounts payable28,70539,95632,11726,62636,24928,237
Accrued liabilities162,180152,564145,611147,038147,464140,049
Debt37,57937,96837,47837,74737,23236,314
Other undisclosed current liabilities263,567283,904270,815268,565263,915269,121
Total current liabilities:492,031514,392486,021479,976484,860473,721
Noncurrent Liabilities
Long-term debt and lease obligation, including:332,947339,313344,428351,442356,080361,862
Long-term debt, excluding current maturities332,900339,300344,400351,400356,100361,900
Other undisclosed long-term debt and lease obligation47132842(20)(38)
Liabilities, other than long-term debt114,522105,044108,226107,064106,277104,804
Deferred income tax liabilities58,03248,05148,01747,21243,22940,635
Other liabilities8488828868458281,418
Operating lease, liability55,64256,11159,32359,00762,22062,751
Total noncurrent liabilities:447,469444,357452,654458,506462,357466,666
Total liabilities:939,500958,749938,675938,482947,217940,387
Equity
Equity, attributable to parent, including:1,199,6261,134,5411,147,7641,125,2041,088,1831,066,514
Treasury stock, value(477,718)(474,854)(473,466)(472,821)(469,243)(468,626)
Additional paid in capital825,138818,201809,655803,361795,063787,177
Retained earnings852,168791,156811,537794,626762,325747,925
Other undisclosed equity, attributable to parent383838383838
Equity, attributable to noncontrolling interest45,44845,42452,67553,68254,47153,269
Total equity:1,245,0741,179,9651,200,4391,178,8861,142,6541,119,783
TOTAL LIABILITIES AND EQUITY:2,184,5742,138,7142,139,1142,117,3682,089,8712,060,170

Income Statement (P&L) ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Revenues594,781598,052587,671591,187571,414 
Cost of revenue(334,109)(1,201,297)(337,568)(326,987)(535,524)284,096
Cost of product and service sold(334,050)(344,614)(337,563)(326,933)(321,537) 
Gross profit:260,672(603,245)250,103264,20035,890284,096
Operating expenses(217,313)583,621(219,774)(211,986)(4,271)13,604
Other undisclosed operating loss      (263,691)
Operating income (loss):43,359(19,624)30,32952,21431,61934,009
Nonoperating income (expense)47,846396(1,342)(2,984)(4,392)(4,811)
Investment income, nonoperating50,9662,7492,0171,6171,727818
Other nonoperating income1,5082,6742,5221,7791,0901,211
Interest and debt expense(6,422)(6,978)(7,772)  (8,234)
Income (loss) from continuing operations before equity method investments, income taxes:84,783(26,206)21,21549,23027,22720,964
Other undisclosed income from continuing operations before income taxes6,4226,9787,772  8,234
Income (loss) from continuing operations before income taxes:91,205(19,228)28,98749,23027,22729,198
Income tax expense(29,384)(6,291)(12,473)(16,657)(12,633)(10,178)
Net income (loss):61,821(25,519)16,51432,57314,59419,020
Net income (loss) attributable to noncontrolling interest(809)5,138397(272)(194)302
Net income (loss) available to common stockholders, diluted:61,012(20,381)16,91132,30114,40019,322

Comprehensive Income ($ in thousands)

6/30/2025
Q2
3/31/2025
Q1
12/31/2024
Q4
9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
Net income (loss):61,821(25,519)16,51432,57314,59419,020
Comprehensive income (loss):61,821(25,519)16,51432,57314,59419,020
Comprehensive income (loss), net of tax, attributable to noncontrolling interest(809)5,138397(272)(194)302
Comprehensive income (loss), net of tax, attributable to parent:61,012(20,381)16,91132,30114,40019,322

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: